A01K 2227/50
Amphibians
Official title: Amphibians, e.g. Xenopus
A01K2227/50 (Amphibians) appears on 44 US grants and 42 published applications in this corpus.
Search patents in A01K- Granted patents
- 44
- Published applications
- 42
- Assignees
- 35
- Inventors
- 77
- Latest grant
- 9 May 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 9 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 3 |
| 2003 | 6 | 5 |
| 2004 | 2 | 4 |
| 2005 | 2 | 6 |
| 2006 | 3 | 3 |
| 2007 | 1 | 3 |
| 2008 | 1 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 2 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Motor neuron-specific expression vectors9 May 2023US 11,642,423 B2The Salk Institute for Biological Studies
- Motor neuron-specific expression vectors4 Aug 2020US 10,729,790 B2The Salk Institute for Biological Studies
- Development of YY male fish broodstocks in a single generation5 May 2020US 10,638,733 B2Fisheries Management Solutions, Inc.
- Turtle basking platform8 Jan 2019US 10,172,329 B2
- Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment2 Jul 2013US 8,476,484 B2Centre National de la Recherche Scientifique (CNRS)
- Drugs for treating neurodevelopmental disorders26 Dec 2024US 2024/0423933 A1President and Fellows of Harvard College
- Motor neuron-specific expression vectors7 Sep 2023US 2023/0277690 A1The Salk Institute for Biological Studies
- Transgenic fluorescent ornamental amphibians29 Jun 2023US 2023/0200363 A1FireFrogs, Inc.
- Automatic living food dispenser24 Dec 2020US 2020/0396959 A1Verge Exotic Pet Products, LLC
- Motor neuron-specific expression vectors12 Nov 2020US 2020/0353100 A1The Salk Institute for Biological Studies
Most cited
By later US patents
- Compositions and methods for the treatment and diagnosis of immune disorders111US 6,562,343 B1Millennium Pharmaceuticals, Inc. · 2003
- Compositions and methods for the treatment and diagnosis of immune disorders106US 6,414,117 B1Millennium Pharmaceuticals, Inc. · 2002
- Calcium receptor-active molecules72US 6,031,003 ANPS Pharmaceuticals, Inc. · 2000
- Vertebrate embryonic pattern-inducing proteins, and uses related thereto68US 5,844,079 APresident and Fellows of Harvard College · 1998
- Calcium receptor-active molecules67US 6,011,068 ANPS Pharmaceuticals, Inc. · 2000